GBT Announces Upcoming Data Presentations During Virtual Edition of 25th Annual European Hematology Association Congress

NEXT STORY
Smile Direct Club Appoints New Members to Clinical Advisory Board
PREV STORY
New Data for Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001™ for Severe Hemoglobinopathies Accepted for Oral Presentation at the 25th European Hematology Association (EHA) Congress
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ThromboGenics Business Update – FY 2017

Press release                                                          15 March 2018Regulated Information Advancing Preclinical and Clinical Diabetic Eye Disease Portfolio ...

author_avatar
NASDAQ Market News

Theratechnologies annonce l’approbation par la FDA de la percée thérapeutique TROGARZO(MC) (ibalizumab-uiyk) injection, le premier inhibiteur du VIH-1 et premier anticorps monoclonal à action prolongée contre le VIH-1 multi-résistant aux traitements existants

Premier traitement du VIH avec un nouveau mécanisme d’action approuvé en plus de 10 ...

author_avatar
NASDAQ Market News

Apricus Reports Top-Line Phase 2a Data for RayVa(TM), Its Topical Treatment for Raynaud’s Phenomenon

SAN DIEGO, Sept. 17, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...

author_avatar
NASDAQ Market News